Cargando…

MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis

Patients with multiple sclerosis (MS) should be vaccinated against COVID-19. All COVID-19 vaccines are effective and do not appear to carry any additional risk for patients with MS. Patients with MS should get a COVID-19 vaccine as soon as it becomes available. The risks of COVID-19 disease outweigh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamout, Bassem I, Zakaria, Magd, Inshasi, Jihad, Al-Jumah, Mohammad, Zeineddine, Maya, Dahdaleh, Maurice, Bohlega, Saeed, Gouider, Riadh, Alroughani, Raed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386106/ https://www.ncbi.nlm.nih.gov/pubmed/34479111 http://dx.doi.org/10.1016/j.msard.2021.103225

Ejemplares similares

Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study
por: Zeineddine, Maya, et al.
Publicado: (2023)

Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
por: Alroughani, Raed, et al.
Publicado: (2016)

Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
por: Alroughani, Raed A, et al.
Publicado: (2014)

Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries
por: Aljumah, Mohammed, et al.
Publicado: (2013)

Treatment of multiple sclerosis in special populations: The case of refugees
por: Zeineddine, Maya M, et al.
Publicado: (2020)

Multiple sclerosis in the Arabian Gulf countries: a consensus statement
por: Bohlega, Saeed, et al.
Publicado: (2013)

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
por: Yamout, Bassem I., et al.
Publicado: (2018)

Neuromyelitis optica spectrum disorders in the Arabian Gulf: challenges and growing experience
por: Alroughani, Raed, et al.
Publicado: (2020)

Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
por: Achiron, Anat, et al.
Publicado: (2017)

Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
por: AlSharoqi, Isa Ahmed, et al.
Publicado: (2020)

Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020)

A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a
por: Al Jumah, Mohammed, et al.
Publicado: (2021)

COVID19 in Multiple Sclerosis Patients in Dubai: Observational Study
por: Thakre, Mona, et al.
Publicado: (2022)

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
por: Alroughani, Raed, et al.
Publicado: (2019)

Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
por: Inshasi, Jihad, et al.
Publicado: (2021)

Pediatric multiple sclerosis: a review
por: Alroughani, Raed, et al.
Publicado: (2018)

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020)

A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
por: El-Muzaini, Hadeel, et al.
Publicado: (2020)

Correction to: A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
por: El-Muzaini, Hadeel, et al.
Publicado: (2020)

Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study
por: Akhtar, Saeed, et al.
Publicado: (2023)

Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
por: Inshasi, Jihad, et al.
Publicado: (2023)

Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
por: Alroughani, Raed, et al.
Publicado: (2016)

Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region
por: Inshasi, Jihad, et al.
Publicado: (2022)

Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review
por: Alroughani, Raed, et al.
Publicado: (2022)

Status migrainosus as an initial presentation of multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2015)

Replication analysis of variants associated with multiple sclerosis risk
por: Dashti, Mohammad, et al.
Publicado: (2020)

Non-parametric analysis of seasonality in birth and multiple sclerosis risk in second generation of migrants in Kuwait
por: Akhtar, Saeed, et al.
Publicado: (2014)

Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region
por: Yamout, Bassem I, et al.
Publicado: (2020)

Voice-Related Quality of Life in Patients with Multiple Sclerosis
por: Hamdan, Abdul Latif, et al.
Publicado: (2012)

Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
por: Alroughani, Raed, et al.
Publicado: (2017)

Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients
por: Darwish, Hala, et al.
Publicado: (2017)

Economic burden of multiple sclerosis on Kuwait health care system
por: Alowayesh, Maryam S., et al.
Publicado: (2019)

Bipolar Disorder and Multiple Sclerosis: A Case Series
por: Sidhom, Youssef, et al.
Publicado: (2014)

Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care
por: Salama, Sara, et al.
Publicado: (2020)

The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients
por: Al-Serri, Ahmad, et al.
Publicado: (2019)

Spinal segmental myoclonus as an unusual presentation of multiple sclerosis
por: Alroughani, Raed Abdullah, et al.
Publicado: (2015)

COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vcrk14msks5es6knb6av4apc0b